Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a Phase II, randomized study

PURPOSE: To evaluate the effect of immunotherapy on response, survival, and certain immune markers in patients with small cell lung cancer (SCLC) who are receiving chemotherapy. PATIENTS AND METHODS: Patients with SCLC (n = 164) were assigned to receive either chemotherapy alone (group A) or a combi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zarogoulidis, Konstantinos, Ziogas, Eftimios, Boutsikou, Efimia, Zarogoulidis, Paul, Darwiche, Kaid, Kontakiotis, Theodoros, Tsakiridis, Kosmas, Porpodis, Konstantinos, Latsios, Dimitrios, Chatzizisi, Olga, Karapantzos, Ilias, Li, Qiang, Kyriazis, Georgios
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2013
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3726438/
https://ncbi.nlm.nih.gov/pubmed/23901264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S43184
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados